Search research articles
Contact Us
Filters
Showing results (281-290 of 667) with videos related to
Page
of 67
Sort By:
Nature Communications
|
January 4, 2019
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Yen-Ting Lai, Tao Wang, Sijy O'Dell, et al.
Cell Reports
|
April 9, 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
Jason Gorman, Gwo-Yu Chuang, Yen-Ting Lai, et al.
The Journal of Infectious Diseases
|
March 27, 2018
Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection
Deogratius Ssemwanga, Nicole A Doria-Rose, Andrew D Redd, et al.
Nature
|
November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang, Gilad Ofek, Leo Laub, et al.
The Journal of Infectious Diseases
|
October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains
Andrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
Cell Host & Microbe
|
September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Immunity
|
May 26, 2019
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Till Schoofs, Christopher O Barnes, Nina Suh-Toma, et al.
The Lancet. HIV
|
March 31, 2023
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
Sharana Mahomed, Nigel Garrett, Edmund V Capparelli, et al.
Research Square
|
October 27, 2023
Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains
Shixia Wang, Kun-Wei Chan, Danlan Wei, et al.
Annals of the Rheumatic Diseases
|
November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M Mosca, C Tani, M Aringer, et al.
Page
of 67
Search research articles
Search
Showing results (281-290 of 667) with videos related to
Sort By:
Page
of 67
Nature Communications
|
January 4, 2019
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Yen-Ting Lai, Tao Wang, Sijy O'Dell, et al.
Cell Reports
|
April 9, 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
Jason Gorman, Gwo-Yu Chuang, Yen-Ting Lai, et al.
The Journal of Infectious Diseases
|
March 27, 2018
Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection
Deogratius Ssemwanga, Nicole A Doria-Rose, Andrew D Redd, et al.
Nature
|
November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang, Gilad Ofek, Leo Laub, et al.
The Journal of Infectious Diseases
|
October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains
Andrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
Cell Host & Microbe
|
September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Immunity
|
May 26, 2019
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Till Schoofs, Christopher O Barnes, Nina Suh-Toma, et al.
The Lancet. HIV
|
March 31, 2023
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
Sharana Mahomed, Nigel Garrett, Edmund V Capparelli, et al.
Research Square
|
October 27, 2023
Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains
Shixia Wang, Kun-Wei Chan, Danlan Wei, et al.
Annals of the Rheumatic Diseases
|
November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M Mosca, C Tani, M Aringer, et al.
Page
of 67